The National Accreditation Program for Breast Centers (NAPBC), a quality program administered by the American College of Surgeons (ACS), has granted accredited status to Reading Hospital. To achieve NAPBC accreditation, Reading Hospital demonstrated compliance with the NAPBC standards for leadership, clinical services, research, community outreach, professional education, and quality improvement for patients. Breast centers seeking NAPBC accreditation undergo a site visit every three years.
“I’m extremely proud of the team at McGlinn Cancer Institute,” said Charles F. Barbera, MD, Reading Hospital President and CEO. “Our team not only met the standards set by the American College of Surgeons, but exceeded them.”
As an NAPBC-accredited center, Reading Hospital is committed to maintaining excellence in the delivery of comprehensive, patient-centered, multidisciplinary treatment resulting in high-quality care for patients with breast disease. Patients can be confident that their breast care team includes healthcare professionals from a variety of disciplines who are committed to working together to provide the best care available throughout their entire course of treatment. NAPBC accreditation means patients receiving care at McGlinn Cancer Institute also have access to information on clinical trials, new treatment options, genetic counseling, and patient-centered services that include psychosocial support, rehabilitation services, and survivorship care.
“Congratulations to the entire team at Reading Hospital for this recognition from the NAPBC,” said Suzanne Wenderoth, MD, Chief Medical Officer at Tower Health and Reading Hospital. “Our team puts in countless hours to provide the highest-quality care to our patients, and this accreditation demonstrates their ongoing commitment.”
Michael Brown, MD, Medical Director for McGlinn Cancer Institute at Reading Hospital, added, “Caring for the women in our community as they bravely navigate a breast disease diagnosis is an honor for the team at Reading Hospital. Each day we focus on providing the best care to our patients.”
To learn more about McGlinn Cancer Institute at Reading Hospital, visit towerhealth.org/McGlinn-Cancer-Institute.
About Reading Hospital
Reading Hospital is the flagship, Magnet Recognized, acute care hospital of Tower Health. Located in West Reading, Pa., Reading Hospital is a 697-bed hospital that is home to many top-tier specialty care centers, including Reading HealthPlex, McGlinn Cancer Institute, Miller Regional Heart Center, Emergency Department, Level I Trauma Center and Beginnings Maternity Center, which houses the region's only Level III Neonatal Intensive Care Unit (NICU). With more than 1,000 physicians, specialists, and advanced practice providers across 49 locations, Reading Hospital has been recognized for its quality outcomes and clinical expertise across service lines. It is listed as one of America's 100 Best Hospitals for four consecutive years (and moving up to America’s 50 Best Hospitals in 2022) and received a 5-Star Rating from CMS two years in a row. For more information, visit towerhealth.org.